title: FDA panel recommends approval of deferiprone.
authors.forename: Miriam
authors.initials: M
authors.lastname: Shuchman
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced; D000077543:Deferiprone; D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D056687:Off-Label Use; D011728:Pyridones / Q000627:therapeutic use*; D013789:Thalassemia / Q000188:drug therapy*; D065227:Transfusion Reaction; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone